Dr Ingo Lehrke, Managing Director, Labtec Pharma

”Very effective, useful portal allowing small companies to play big companies”, – Dr Lehrke’s summary of Pharmalicensing

Germany-based Labtec Pharma designs and develops innovative drug delivery systems such as transdermal, buccal and gingival delivery and fast dissolving dosage forms. It also researches and develops contract analytics and stability testing according to the ICH standards.

Dr Ingo Lehrke, Managing Director at Labtec Pharma spoke to Pharmalicensing about his time and experience with the partnering company since first profiling a few years ago. “Pharmalicensing has many useful features; the licensing opportunities are easy to use and are effective, and inclusion on the website gives a strong visibility to the pharma industry. The cost of joining is affordable too.”

What makes Pharmalicensing different?

“The site is clear and the company has good customer relationships. It’s nice to receive a regular call from the same member of the Pharmalicensing team every month; my personal business development representative knows my history and what has been successful for me.” Dr Lehrke was also pleased with the website’s facilities “The search engine produces excellent results and we get good responses from our email alerts. The monthly reports are also useful”

The Pharmalicensing effect

Earlier this year Labtec Pharma placed a new press release and three licensing opportunities on the Pharmalicensing website. After the release of this company information, Labtec Pharma received three to four times more interest on its profile and a significant increase of clicks to its website.

Dr Lehrke says that profiling with Pharmalicensing has allowed Labtec Pharma to reach companies and contacts that it would not normally reach. The company has initiated some licensing agreements with companies contacted through Pharmalicensing. “In the future I hope that Labtec’s inclusion on Pharmlicensing should lead to more deals for the company,” commented Dr Lehrke. “I am currently recommending Pharmalicensing to Corporate Officers at Schwarz Pharma in Mannheim, Germany.”

View Labtec Pharma’s company profile

View Labtec Pharma's licensing opportunities

To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article, please contact the editors.

The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing or UTEK Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.